Press release
Locally Advanced Pancreatic Cancer Market Report Examines Industry Trends, Growth Drivers And Future Outlook
Locally Advanced Pancreatic Cancer Market
Forecasted Market Size and Growth Trajectory of the Locally Advanced Pancreatic Cancer Market
The market for locally advanced pancreatic cancer treatments is projected to reach $1.71 billion by 2030, growing at an impressive compound annual growth rate (CAGR) of 10.2%. This upward trend is fueled by the broader use of combination therapy protocols, increased adoption of stereotactic body radiation therapy (SBRT), and heightened investment in pancreatic cancer research. Additional drivers include a stronger focus on personalized oncology approaches and greater accessibility to advanced treatment centers worldwide. Key market trends during the forecast period involve expanded use of combination chemotherapy regimens, growing preference for neoadjuvant therapies, emphasis on tumor downstaging to improve surgical eligibility, broader application of radiation therapy for local disease control, and enhanced multidisciplinary treatment planning.
The locally advanced pancreatic cancer market size has grown rapidly in recent years. It will grow from $1.05 billion in 2025 to $1.16 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to late-stage diagnosis of pancreatic cancer, limited surgical eligibility in locally advanced cases, historical reliance on gemcitabine-based chemotherapy, poor overall survival rates, growing hospital-based oncology care.
Download a free sample of the locally advanced pancreatic cancer market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21214&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Prominent Industry Players in the Locally Advanced Pancreatic Cancer Market
Several leading pharmaceutical and biotechnology companies dominate the locally advanced pancreatic cancer sector. Among the top players are Pfizer Inc, F Hoffmann La Roche Ltd, Merck and Co Inc, Bristol Myers Squibb Company, AstraZeneca plc, AbbVie Inc, Novartis AG, GSK plc, Bayer AG, Eli Lilly and Company, Ipsen, Takeda Pharmaceutical Company Limited, Amgen Inc, Sanofi, Servier, NovoCure Limited, Halozyme Therapeutics, Clovis Oncology, Astellas Pharma, and BeiGene. These companies are actively engaged in developing and marketing cutting-edge therapies to improve patient outcomes.
Significant Acquisition Enhancing the Oncology Portfolio of AstraZeneca
In June 2024, AstraZeneca Plc, a UK-based pharmaceutical giant, acquired Fusion Pharmaceuticals Inc. for $2.5 billion. This strategic move aims to strengthen AstraZeneca's oncology offerings by incorporating advanced radiopharmaceuticals like FPI-2265, boosting the company's research, development, and manufacturing capacities. Additionally, the acquisition supports AstraZeneca's goal to accelerate the transition toward targeted cancer therapies and expand its footprint in Canada. Fusion Pharmaceuticals Inc., headquartered in Canada, specializes in developing targeted cancer treatments, including therapies for pancreatic cancer.
View the full locally advanced pancreatic cancer market report:
https://www.thebusinessresearchcompany.com/report/locally-advanced-pancreatic-cancer-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Focus on Orphan Drugs to Address Critical Gaps in Treatment
Key market players are prioritizing the development of innovative products such as orphan drugs to meet the urgent medical needs linked with locally advanced pancreatic cancer. Orphan drugs target rare diseases affecting small patient populations and benefit from incentives like tax breaks and market exclusivity to encourage their development. For example, in January 2025, Actuate Therapeutics Inc., a US-based biopharmaceutical firm, announced that its drug Elraglusib-a novel GSK-3β inhibitor-received Orphan Drug Designation from both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for treating pancreatic ductal adenocarcinoma (PDAC), a form of locally advanced pancreatic cancer. This designation highlights Elraglusib's potential in filling significant treatment gaps, bolstered by promising Phase 2 trial results demonstrating meaningful clinical improvements and anti-tumor activity in patients with metastatic PDAC.
Breakdown of the Locally Advanced Pancreatic Cancer Market by Key Segments
The market report segments the locally advanced pancreatic cancer space into several categories to provide a detailed analysis:
1) Therapy Types: Chemotherapy and Radiation Therapy
2) Routes of Administration: Oral, Injectables, and Other Methods
3) End-User Groups: Hospitals, Specialty Clinics, Research Institutions, and Other End-Users
Further subsegments include:
- Chemotherapy: Gemcitabine-based Chemotherapy and FOLFIRINOX Chemotherapy
- Radiation Therapy: External Beam Radiation Therapy and Stereotactic Body Radiation Therapy (SBRT)
This segmentation offers a comprehensive view of the diverse treatment modalities and delivery methods shaping the market landscape.
Expanded capabilities in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Locally Advanced Pancreatic Cancer Market Report Examines Industry Trends, Growth Drivers And Future Outlook here
News-ID: 4609339 • Views: …
More Releases from The Business Research Company
Maprotiline Hydrochloride API Market Report 2026 Market Outlook Supported By A F …
The pharmaceutical ingredients sector, especially for mental health treatments, is evolving rapidly as demand for effective and affordable solutions rises. Among these, the maprotiline hydrochloride API market is gaining significant traction, driven by various factors including manufacturing trends and regulatory demands. Here's a detailed look into its projected growth, key players, market segmentation, and emerging trends.
Market Size and Growth Expectations in the Maprotiline Hydrochloride API Market
Forecasts indicate that…
Mammalian Cell Fermentation Technology Market Insights Highlight Segment Expansi …
The mammalian cell fermentation technology sector is poised for significant expansion as advancements in biopharmaceutical production and personalized medicine continue to accelerate. This market is evolving rapidly, driven by increasing demands for biologics and innovative manufacturing techniques, which are reshaping the landscape of drug development and production.
Expected Growth Trajectory of the Mammalian Cell Fermentation Technology Market
The mammalian cell fermentation technology market is forecasted to experience substantial growth, reaching…
Malignant Mesothelioma Market Report Evaluates Growth Drivers, Challenges And Ma …
The market for malignant mesothelioma treatments is poised for notable expansion as innovative therapies and improved diagnostic tools emerge. With growing attention to rare cancers and increasing investments in oncology, this sector is expected to experience robust growth over the coming years. Let's explore the current market size, influential players, evolving trends, and key segments shaping the future landscape of malignant mesothelioma care.
Malignant Mesothelioma Market Size and Growth Projections Through…
Malaria Vaccines Market Report Provides Insights Into Market Evolution And Growt …
The malaria vaccine landscape is on the cusp of remarkable expansion, driven by breakthroughs in science and increasing global efforts to combat this deadly disease. Understanding the market's future size, key contributors, and emerging trends offers valuable insight into how this vital healthcare segment is evolving. Let's explore the projected growth, leading companies, and the innovations shaping the malaria vaccines market.
Projected Market Value and Growth of the Malaria Vaccines Market…
More Releases for Locally
Acepak Spotlights Locally Made End-of-Line Packaging Machines
Cape Town, June 2026. As the South African manufacturing sector moves through the middle of the year and producers begin mapping out capacity for the busier months ahead, Acepak is drawing attention to the role of locally designed and built end-of-line packaging equipment. The family-owned business, which has spent more than four decades in the industry, designs, engineers, assembles and tests its machines in Cape Town, and it is using…
Peyman Farzinpour on Why Arts Access Matters Locally
Image: https://www.globalnewslines.com/uploads/2026/02/1770823176.jpg
Peyman Farzinpour, Los Angeles, California
Peyman Farzinpour, Los Angeles-based conductor and educator, reflects on how access to the arts shapes individuals, communities, and the future of creative work in Southern California.
Los Angeles, CA - National conversations about arts access often focus on big-picture funding and policy debates. But for Peter Peyman Farzinpour, the issue is grounded in everyday experience. As a conductor, composer, educator, and arts leader with deep professional…
Justin Brewer Highlights How Hidden Business Costs Hit Connecticut Locally
Connecticut, US, 14th January 2026, ZEX PR WIRE, Entrepreneur and Greenhub Founder Justin Brewer, originally from Somers, Connecticut, is drawing attention to a broader issue he says quietly affects many local businesses: confusing systems and hidden operating costs that drain time, energy, and margins. In a recent feature interview, Brewer reflected on how this challenge shows up not only nationally, but right across Northern Connecticut and the wider New England…
Arch House Deli – launches range of locally inspired hampers
Arch House Deli (Clifton Village, Bristol, UK) has launched a range of hampers based on food from local producers in Bristol and Bath.
During 2012 the deli has built relationships with local niche food suppliers and has developed a range of hampers selecting the very best from the Bristol and Bath area.
“Our vision for our products is to source local, sustainable, traceable and organic where ever possible. Only if…
BluePrint Data Provides Free Locally Installable OEM Internet Filtering Software
OEM Internet Filtering provider and leader in high quality OEM internet content filtering solutions BluePrint Data is expanding its integration tools and utilities with the addition of a locally installable “Content Engine”. The configurable software, provided free by BluePrint Data, enables companies to have a locally installable “URL Lookup” tool for a plethora of devices from local home or small business routers to network gateway appliances or data center…
Locally Made Skincare Products Outperform Major Companies
Customers from around the world write in to share how Natural Family Botanical skincare products have succeeded where store-bought products have failed. G
Merlin, OR - November, 2010 -- Devised with a fresh perspective and all-natural ingredients, there are no better products for sensitive or reactive skin than the formulas of Kelly Frohnauer, founder and owner of Natural Family Botanicals.
Men and women of all ages are discovering their true reflections, free…
